Friday, 20 November 2026European Markets

NANOBIOTIX Stock Was 13.53% Up Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - the market ended the session with nanobiotix (nano.pa) rising 13.53% to €8.56 on monday while cac 40 dropped 0.07% to €7,427.31.

nanobiotix's last close was €7.54, 0.79% under its 52-week high of €7.60.

about nanobiotix

nanobiotix s.a., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. its lead product candidate is nbtxr3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. nanobiotix s.a. has a partnership with lian oncology limited to develop and commercialize nbtxr3 in greater china, south korea, singapore, and thailand. nanobiotix s.a. was incorporated in 2003 and is headquartered in paris, france.

earnings per share

as for profitability, nanobiotix has a trailing twelve months eps of €-1.74.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, nanobiotix's stock is considered to be oversold (<=20).

volatility

nanobiotix's last week, last month's, and last quarter's current intraday variation average was 6.17%, 2.29%, and 5.53%.

nanobiotix's highest amplitude of average volatility was 6.17% (last week), 5.61% (last month), and 5.53% (last quarter).

revenue growth

year-on-year quarterly revenue growth grew by 159.6%, now sitting on 4.78m for the twelve trailing months.

moving average

nanobiotix's value is way above its 50-day moving average of €5.01 and way above its 200-day moving average of €3.95.

more news about nanobiotix (nano.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 24 Jul 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›